Journal List > Endocrinol Metab > v.27(4) > 1085969

TOOLS
Seo and Lee: APOA5 Polymorphism Is Associated with Metabolic Syndrome in Korean Postmenopausal Women
Editorial
Endocrinology and Metabolism

Endocrinology and Metabolism 2012; 27(4): 274-275.

Published online: 20 December 2012

DOI: https://doi.org/10.3803/EnM.2012.27.4.274

APOA5 Polymorphism Is Associated with Metabolic Syndrome in Korean Postmenopausal Women

Mi Hae Seo, Won Young Lee

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Copyright © 2012 Korean Endocrine Society

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002. 287:356–359.
2. Oh SW. Obesity and metabolic syndrome in Korea. Diabetes Metab J. 2011. 35:561–566.
3. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003. 88:2404–2411.
4. Kim DH, Lee SH, Han KH, Kim CB, Song KY, Cho S, Lee KH. APOA5 polymorphism is associated with metabolic syndrome in Korean postmenopausal women. Endocrinol Metab. 2012. 27:276–281.
5. Song HO, Kim SS. A literature review of single nucleotide polymorphisms in obesity genes. J Korean Orient Assoc Stud Obes. 2004. 4:139–160.
6. Berg GA, Siseles N, González AI, Ortiz OC, Tempone A, Wikinski RW. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause. 2001. 8:51–57.
7. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989. 321:641–646.
8. Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest. 1997. 27:322–326.
9. Song KH, Yu SG, Cha S, Kim JY. Association of the apolipoprotein A5 gene -1131T>C polymorphism with serum lipids in Korean subjects: impact of sasang constitution. Evid Based Complement Alternat Med. 2012. 2012:598394.
10. Lee KH, Kim OY, Lim HH, Lee YJ, Jang Y, Lee JH. Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women. Metabolism. 2010. 59:1583–1590.
11. Nabika T, Nasreen S, Kobayashi S, Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis. 2002. 165:201–204.
12. Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, Watanabe S, Ichihara S, Yoshida H, Satoh K, Nozawa Y. Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 2007. 191:298–304.
13. Cardona F, Guardiola M, Queipo-Ortuño MI, Murri M, Ribalta J, Tinahones FJ. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study. Atherosclerosis. 2009. 206:148–152.
14. Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta. 2009. 402:83–87.
TOOLS
Similar articles